"We can finally see the light at the end of the tunnel in the fight against inflation," said Joe Nellis, economic adviser at business-services firm MHA. "This significant milestone comes a day after ...
The announcement, which came a day earlier than ASML's scheduled release because of a technical error, sparked a global selloff in chip stocks, from Nvidia to Intel and Taiwan Semiconductor ...
Goldman Sachs first debuted the GRANOLAS acronym - standing for GSK (GSK), Roche, ASML (ASML), Nestle, Novartis (NVS), Novo Nordisk (NVO), L'Oreal, LVMH, AstraZeneca (AZN), SAP (SAP) and Sanofi (SNY) ...
The British pound plunged below $1.30 and government bond yields dived after a report showing U.K. inflation dropped sharply to its lowest level in more than three years prompted traders to increase ...
U.S. futures for the S&P 500 were down 0.1% and futures for the Dow Jones Industrial Average fell 0.1%. Changes in futures do not necessarily predict movements after the opening bell. In Europe, the ...
European luxury stocks fell after third-quarter results from industry bellwether LVMH dashed hopes that a sector recovery is under way and renewed concerns over the Chinese market.
Bank Indonesia has hit the pause button a month after kicking off its easing cycle, breaking with its tendency for back-to-back cuts as it shifts focus back to stabilizing the rupiah.
A selloff in chip stocks dragged major indexes lower after Dutch chip-equipment manufacturer ASML noted growing caution among its customers and said sales this year could come at the lower end of ...
The Philippine central bank cuts its policy rate for the second time this year as it looks to bolster its economy amid mounting uncertainty abroad. Bangko Sentral ng Pilipinas Gov. Eli Remolona said ...
Thailand's central bank has joined the ranks of monetary authorities who are easing monetary policy, surprising markets with a rate cut to help boost its economy. The Bank of Thailand said Wednesday ...
GSK said that its urinary tract infections treatment gepotidacin has been accepted for priority review by the U.S.'s Food and Drug Administration.